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Slice culturesThe formation of CNS myelin is dependent on the differentiation of oligodendrocyte precursor cells (OPCs)
and oligodendrocyte maturation. How the initiation of myelination is regulated is unclear, but it is likely to
depend on the development of competence by oligodendrocytes and receptivity by target axons. Here we
identify an additional level of control of oligodendrocyte maturation mediated by interactions between the
different cellular components of the oligodendrocyte lineage. During development oligodendrocyte
precursors mature through a series of stages deﬁned by labeling with monoclonal antibodies A2B5 and O4.
Newly differentiated oligodendrocytes begin to express galactocerebroside recognized by O1 antibodies and
subsequently mature tomyelin basic protein (MBP)-positive cells prior to formation of compact myelin. Using
an in vitro brain slice culture system that supports robust myelination, the consequences of ablating cells at
different stages of the oligodendrocyte lineage on myelination have been assayed. Elimination of all OPC
lineage cells through A2B5+, O4+, and O1+ complement-mediated cell lysis resulted in a delay in
development of MBP cells and myelination. Selective elimination of early OPCs (A2B5+) also unexpectedly
resulted in delayed MBP expression compared to controls suggesting that early OPCs contribute to the timing
of myelination onset. By contrast, elimination of differentiated (O1+) immature oligodendrocytes
permanently inhibited the appearance of MBP+ cells suggesting that oligodendrocytes are critical to
facilitate the maturation of OPCs. These data illuminate that the presence of intra-lineage feed-forward and
feedback cues are important for timely myelination by oligodendrocytes., Case Western Reserve Univer-
44106, USA. Fax: +1 216 368
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The development of oligodendrocytes, the myelinating cells of the
vertebrate central nervous system (CNS), has been studied exten-
sively. In vivo oligodendrocyte precursors (OPCs) arise from neural
stem cells in distinct regions of the embryonic neural tube as a result
of localized signals that modulate the activity of a number of
transcription factors such as the Olig genes. These OPCs migrate
widely through the CNS in response to selected guidance cues and
proliferate extensively in response to growth factors such as PDGF
(Bogler et al., 1990) prior to differentiating and myelinating adjacent
axons in a reproducible pattern. In vitro analyses of OPC development
have been facilitated through cell culture and the utilization of
antibodies or gene transcripts that distinguish particular stages in OPC
development. Each stage is characterized by changes in proliferation,
migratory abilities, and morphology (Bansal et al., 1989; Hardy andReynolds, 1993; Lubetzki et al., 1991). Oligodendrocyte precursors
(OPCs) express NG2 and mAb A2B5 (Raff, 1989; Raff et al., 1984a)
(Raff et al., 1984b) and proliferate in response to platelet-derived
growth factor (PDGF) (Noble et al., 1988; Richardson et al., 1988).
Recent evidence suggests OPCs have stem cell-like properties and can
generate astrocytes and neurons in addition to oligodendrocytes
(Kondo and Raff, 2004). Later in development, labeling with mAb O4
identiﬁes OPCs and immature oligodendrocytes (Bansal et al., 1992).
Newly differentiated oligodendrocytes begin to express galactocer-
ebroside recognized by mAb O1 that, with further maturation,
expresses myelin basic protein (MBP) followed by the full spectrum
of myelin components and elaboration of compact myelin sheaths
(Miller, 2002; Rosenberg et al., 2007).
Several mechanisms have been implicated in regulating the
progression of OPCs to a myelinating cell. Clonal studies suggested
the presence of a cell intrinsic timing mechanism controlling
oligodendrocyte differentiation (Barres et al., 1994; Temple and
Raff, 1986), a component of which may be the transcription factor
GM98 (Emery et al., 2009), while the proliferative capacity of OPCs is
mediated in part by p57Kip2 (Dugas et al., 2007). The cell intrinsic
program of OPC differentiation is subject to signiﬁcant external
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(FGF) and PDGF, OPCs continue to proliferate and fail to differentiate
(McKinnon et al., 1993; Noble et al., 1988; Raff et al., 1988).
Conversely, withdrawal of growth factors stimulates precocious OPC
differentiation.
Several lines of evidence implicate interactions between cells of
the oligodendrocyte lineage in regulating their behavior. Culture
studies demonstrated that the ﬁnal number of oligodendrocytes that
develop is independent of the number of OPCs in the initial culture
suggesting the lineage reaches equilibrium (Zhang and Miller, 1996).
Similarly over-expression of PDGF in vivo generates more OPCs but no
change in the ﬁnal number of oligodendrocytes (Calver et al., 1998;
Richardson et al., 1988). These normalizations of cell number may
reﬂect a density-dependent inhibition of OPC proliferation mediated
through control of P27KIP1 and Rb phosphorylation (Nakatsuji and
Miller, 2001) as well as increases in oligodendrocyte apoptosis (Calver
et al., 1998; Richardson et al., 1988). Further evidence of intra-OPC
lineage interactions comes from the characterization of the fate of
OPCs from distinct sources in the developing forebrain and suggests
that competition during normal development between early and late
generated OPCs results in the elimination of cohorts of cells (Kessaris
et al., 2006).
During development, not all OPCs undergo differentiation into
myelinating oligodendrocytes. Early studies identiﬁed “adult OPCs”
that proliferate more slowly and in response to different mitogens
than their embryonic counterparts (Bogler et al., 1990; Nishiyama
et al., 1999; Wolswijk and Noble, 1992). Subsequently these adult
OPCs have been shown to persist in signiﬁcant numbers throughout
life and their characterization in vivo reveals unique physiological
properties implicating them in control of axonal excitability (De Biase
et al., 2010; Karadottir et al., 2008; Nishiyama et al., 1999; Wolswijk
and Noble, 1992; Woodruff et al., 2004; Ziskin et al., 2007). Whether
these cells represent a reservoir of OPCs for remyelination by
replacing oligodendrocytes lost during adulthood is unclear. Remye-
lination can occur in the adult CNS; however, in certain pathological
conditions such as chronic demyelinated plaques seen in multiple
sclerosis remyelination fails even though these regions contain cells
with the characteristics of OPCs (Chang et al., 2000; Rudick and Trapp,
2009). Why these OPCs that are surrounded by naked axons fail to
myelinate is currently unclear.
Slice cultures are emerging as an effective model with which to
assess the regulation of myelination (Harrer et al., 2009). Using
complement-mediated lysis to selectively eliminate distinct stages of
the developing OPC population in slice and dissociated cell culture, we
show that the timely maturation of oligodendrocytes is dependent on
all stages of the lineage. Oligodendrocyte maturation is delayed by
selective removal of early OPCs but inhibited by selective removal of
newly generated oligodendrocytes. These studies suggest interde-
pendence among the cellular components of the oligodendrocyte
lineage and reveal a novel regulation of oligodendrocyte maturation
that may have important implications for development of effective
myelin repair strategies.
Materials and methods
Preparation of postnatal rat brain slice culture
All animals were purchased from Harlan Laboratories (Indianapo-
lis, IN) and housed in the ARC facility of Case Western Reserve
University School of Medicine. The Case ARC facility is fully accredited
by the Association for Assessment and Accreditation of Laboratory
Animal Care. All animal procedures were approved by the Institu-
tional Animal Care and Use Committee of Case Western Reserve
University. Timed pregnant Sprague–Dawley (SD) rats were pur-
chased and P2 rat brains dissected and kept in ice-cold PBS buffer
supplemented with 10% glucose (Sigma, USA) prior to embedding in1% agar. Slices were taken from a region encompassing 1.1–0.2 relative
to Bregma. All images and quantiﬁcationwere obtained from the region
of themotor cortex, cingulum, and underlying subcortical whitematter.
Slice cultures were prepared from 250-μm-thick coronal slices using a
Leica vibratingmicrotome (Leica, VT1000S, Germany) and immediately
placed into cell-culture inserts (0.4 μm, Millicell-CM, Millipore) and
cultured in six-well culture dishes containing basal medium eagle
(BME) medium supplement with 25% horse serum, 0.5% glucose, 2.5%
Hank's solution, and 1% L-glutamine. Slices were grown at 37 °C/5% CO2,
and the growth medium changed every second day.
Preparation of dissociated cell cultures
The brain region containing the corpus callosumwas isolated from
P2 SD rats, chopped and digested in trypsin with 0.25% EDTA in MEM
for 20–25 min at 37 °C. Cell suspensions were ﬁltered through a 30-
μm nylon mesh to remove large tissue clumps and cells plated on 12-
mm glass coverslips coated with poly-L-lysine (Sigma) at a density of
2×105 cells/coverslip. Cells were grown in medium (DMEM medium
supplemented with 1% FBS-c, PDGF and N2) overnight before
antibody-complement treatment using a protocol described below.
Preparation of slices for electron microscopy
To assess the extent of myelination 1 μm Epon embedded sections
were labeled with Toluidine blue and ultrathin sections were
examined on a Joel 100CX electron microscope at 80 KV. Slices were
ﬁxed in glutaraldehyde (2%) and paraformaldehyde (4%) followed by
1% OsO4, block stained with saturated uranyl acetate, dehydrated
through graded alcohols, and embedded in Epon 812. Sections were
cut in a plane parallel to the surface of the slice.
Antibodies and complement-mediated cell lysis
The primary antibodies used in the study include the following:
mouse monoclonals A2B5, O4, and O1 IgM hybridoma supernatant as
previously described (Gao et al., 2006; Tsai et al., 2006). NG2+ cells
were identiﬁed by labeling with the anti-NG2 chondroitin sulfate
proteoglycan rabbit polyclonal antibody (Millipore, AB5320). A
mouse monoclonal antibody against MBP (Covance, Princeton, NJ)
was used as a marker of mature oligodendrocytes. Polyclonal rabbit
Neuroﬁlament 200 antibody was used to label axons (Sigma, N4142).
Anti-iba-1 polyclonal antibody (Wako Chemicals USA, Inc., VA),
puriﬁed from rabbit antisera with speciﬁc reactivity to microglia
and macrophages, was used to assess microglial response. Guinea Pig
complement was purchased from Sigma (St. Louis, MO), and cells
were eliminated using the following protocol: P2 coronal slices were
sectioned and incubated at 37 °C incubation overnight. The following
day, slices were incubated in A2B5, O4, or O1 antibodies diluted 1:1 in
10% horse serum in BME at 37 °C for 60 min. Guinea pig complement
was then added at a dilution of 1:10 and incubated for 2 h at 37 °C.
After washing with BME, the slices were maintained in growth
medium overnight. To ensure the majority of the selected cell
population was depleted, the procedure was repeated the following
day. Following antibody-mediated complement cell lysis, slices
were maintained at various time points (P2+3 DIV, P2+7 DIV, and
P2+14 DIV) prior to immunostaining. Controls included incubation
in complement or antibody alone and neither signiﬁcantly altered the
number of oligodendrocyte lineage cells in the slice. To assess the
effectiveness of the cell depletion, slices were labeled with the same
antibodies 24 h after complement treatment. Primary antibody
labeling was visualized by conjugated secondary Alexa antibodies
(Invitrogen, USA) and slices mounted in anti-fading ﬂuorescence
medium with or without DAPI from Vector Laboratories (Burlingame,
CA). The extent of myelination was conﬁrmed by Black-Gold. Black-
Gold (Chemicon, Product# AG390) is a novel haloaurophosphate
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CNS.
Immunocytochemistry and myelin labeling
MBP immunocytochemistry in brain slice culture
Cultured slices were ﬁxed in 4% paraformaldehyde for 30 min at
room temperature. After rinsing in PBS, slices were de-lipidated with
5% acetic acid in 95% ethanol for 20 min at 4 °C, blocked with 10%
normal goat serum in PBS for 1 h at room temperature, and incubated
with primary mouse monoclonal anti-MBP antibody (1:500) over-
night at 4 °C. After rinsing, slices were incubated in ﬂuorescence-
conjugated anti-mouse secondary antibody Alexa 596 (1:500) for 2 h.
Cultured slices were mounted and analyzed using Leica DFC 500
ﬂuorescence or confocal microscope.
Double or single labeling of OPCs in slice cultures
Slice cultures were ﬁxed in 4% paraformaldehyde for 30 min at
room temperature. After washing in PBS, slices were blocked in 5%
goat serum in PBS with 0.03% triton for 20 min at room temperature.
Double immunostaining of polyclonal rabbit Neuroﬁlament 200
(1:250) and MBP (1:500) or single primary antibodies (A2B5, NG2,
O1) were incubated overnight at 4 °C. After rinsing, slices were
incubated in ﬂuorescence-conjugated anti-mouse or anti-rabbit
secondary antibody Alexa 488 (1:500) or 596 (1:1000) for 2 h at
room temperature and labeled slices were mounted on slides.
Immunostaining in dissociated brain cell culture
A2B5, O4, and O1 staining was performed on live cells in
dissociated cell culture as previously described (Nishiyama et al.,
1999; Zhang and Miller, 1996). For labeling with mouse anti-MBP
antibody, cultured cells were ﬁxed with 4% paraformaldehyde and
incubated in mouse monoclonal MBP antibody followed by anti-
mouse secondary antibody Alexa 596 for 2 h at room temperature.
Black-Gold
Slices were ﬁxed with 4% paraformaldehyde for 1 h at room
temperature, transferred into pre-warmed Black-Gold solution at
60 °C (0.2% Black-Gold solution: 100 mg of Black-Gold, 50 ml of 0.9%
NaCl) for 30–40 min. After rinsing, slices were ﬁxed for 3 min in
sodium thiosulfate solution and rinsed, air-dried, and mounted in
Citiﬂuor (Ted Pella, Inc., CA, USA).
Quantiﬁcation of MBP+ expression in brain slice cultures
To quantify the expression of MBP protein in slice cultures, the
histogram statistic feature of Adobe Photoshop CS3was used. For each
antibody-complement treated group, six randomly selected regions
were measured and the intensity of MBP expression was assessed.
Each observation was repeated at least 3 times. The average intensity
value of MBP expression was calculated and compared between
conditions. Each studywas repeated at least 3 times and the datawere
presented as mean±SD. Statistical signiﬁcance was determined using
paired Student's t test or ANOVA test and set at pN0.05.
In slice and dissociated cell cultures, double-blinded cell counts
were performed using a Leica Fluorescence microscope with a 20× or
40× objective lens and a reticule (10×10 grid). For each experiment,
5–9 ﬁelds were randomly selected on each slice or coverslip and the
total number of A2B5+, O1+, orMBP+-immunopositive cells and the
total number of cell nuclei stained with DAPI counted. The number of
immunopositive cells in the total cell number was calculated and
compared between treated cultures and non-treated controls. The
Person Chi-squared or ANOVA test was used for statistical analysis
between treated and non-treated groups. The studies were repeated a
minimum of 3 times and signiﬁcance determined as pN0.05.Results
Development of myelination in slice culture
To deﬁne the timing of oligodendrocytematuration andmyelination
coronal brain slice cultures including corpus callosum established from
postnatal day 2 (P2) forebrain were labeled with anti-MBP antibodies
after different culture intervals. After 3 days in vitro (P2+3 DIV)
individual MBP+ cells were widely distributed throughout the slice.
Within the developingmotor cortex and underlying presumptivewhite
matter, these cells had few short processes (Fig. 1a) that emerged in a
radial manner from the cell body and resembled premyelinating
oligodendrocytes seen in vivo. After 2 additional days in vitro (P2+5
DIV) the number of MBP+ cells increased from approximately 3% to 6%
of total cells and their morphology became more complex (Fig. 1b).
Compared to cells in younger slices, after 5 days in vitro many MBP-
positive cells had an increased number of processes that were
signiﬁcantly longer. Although individual MBP cells occupied a larger
area, the processes from an individual cell rarely overlapped with
adjacent cells. With a further 2 days in vitro (P2+7 DIV), there was no
signiﬁcant increase in the density of MBP+ cells that remained at
approximately 7% of total cells; however, the processes of manyMBP+
cells were oriented parallel to adjacent axons but still did not
signiﬁcantly overlapwith eachother (Fig. 1c). By P2+14DIV a dramatic
up-regulation of MBP+ expression to about 20% of total cells was seen
and both cell bodies and processes had increased MBP expression
(Fig. 1d). Adjacent oligodendrocytes appeared to have formed contin-
uous coverage along neighboring axons and individual oligodendrocyte
domains were no longer discernable. These observations demonstrate
that oligodendrocytematuration follows a similar temporal sequence in
slice cultures as in the intact CNS where myelination begins in the ﬁrst
postnatal week and peaks in the ﬁrst postnatal month (Benjamins and
Morell, 1978).
Regional differences in the pattern of oligodendrocyte develop-
ment and myelination were preserved in slice cultures. In the corpus
callosum of older slices (14 DIV), densely packedMPB+ cell processes
were oriented largely parallel to callosal axons and multiple MBP+
cell bodies were present (Fig. 1d, e). By contrast in cortical regions, the
majority of the MBP+ processes were oriented radially and were far
sparser than in presumptive white matter. A similar pattern was
observed using independent indicators of myelination. For example,
labeling with Black-Gold that stains normal as well as degenerating
myelin demonstrated that the majority of the myelin was oriented
parallel in the corpus callosum (cc) but radially in the cortex (cx)
(Fig. 1e). The close association of the axons and oligodendrocyte
processes was evident in slices double labeled with antibodies to
neuroﬁlament (NF200) and MBP where the labeling appeared
coincident at the level of the light microscope (Fig. 1f, arrows).
Confocal imaging (Fig. 1g) conﬁrmed the organization of the MBP
processes. To unambiguously demonstrate the presence of compact
myelin, slices were prepared for electron microscopy and sections cut
parallel to the surface of the slice. Compared to the robust expression
of MBP and Black-Gold labeling, relatively few compact myelinated
axons were seen (Fig. 1h, arrows). Rather the majority of axons
appeared to be surrounded by oligodendrocyte processes that had yet
to form compact myelin. By 21 DIV extensive myelination was seen
through the slice (data not shown). These data suggest that while the
maturation of oligodendrocytes is efﬁciently supported in slice
cultures, the generation of compact myelin is delayed relative to in
vivo.
Selective ablation of distinct stages of the oligodendrocyte lineage
A powerful approach to understanding the interrelationships
between distinct cell types is to assess the consequences of selective
cell ablation. To determine whether speciﬁc cell subpopulations within
Fig. 1. Development of myelination in rat brain slice cultures. P2 brain coronal slices taken from the region 1.1–02 relative to Bregma were grown in vitro for 3, 5, 7, or 14 days.
Immature MBP+ cells with few processes were seen in the developing motor cortex and underlying white matter at P2+3 DIV (a). In the cultures at P2+5 DIV (b) and P2+7 DIV
(c), more MBP+ cells with extended processes had developed by P2+14 DIV (d), MBP is expressed both in oligodendrocyte cell bodies and in processes surrounding axons. Black-
Gold® staining (e) conﬁrms the presence of myelination in P2+14 DIV slice cultures. The close association of axons and oligodendrocyte process is demonstrated by the high level of
coincidence of MBP (red) co-localized with neuronal axons, which is stained by neuroﬁlament (green) in (f). Confocal imaging (g) conﬁrms that axons are wrapped by MBP+
process. Electron microscopy (EM) shows an axon in longitudinal section surrounded by a compacted myelin sheath (arrows) at P2+14 DIV (h). cx=Cortex, cc=corpus callosum.
Scale bar=25 μm.
Fig. 2. Reduction of A2B5+ or O1+ cells in slice cultures after complement-mediated lysis to selectively ablate A2B5+ or O1+ cells. A dramatic reduction in the number of A2B5+
cells (A, b) was seen following treatment with A2B5 plus complement (A2B5+C), compared to the untreated control (A, a) whereas the density of O1+ cells remains at a similar
level to control (A, e). Likewise, treatment with O1 antibody plus complement resulted in substantial loss of O1+ cells (A, f) while sparing A2B5+ cells (A, c). Quantitative data are
shown in B and C. **pb0.01, treated groups versus controls. Scale bar =25 μm.
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from P2 rat brains were exposed after 1 day in vitro to 2 rounds of
complement-mediated cell lysis using either mAb A2B5 to eliminate
cells early in the lineage, or mAb O1 to eliminate newly formed
oligodendrocytes. Twenty-four hours after the second complement
treatment slices were labeled with A2B5 or O1 antibodies and the
number of labeled cells was determined. In slices treated with A2B5
antibody and complement, the number of A2B5+ cells was reduced
dramatically 24 h later (Fig. 2A, b) with the residual labeling mainly on
cell debris. By contrast the number of O1+ cells was essentially
unaffected compared to controls (Fig. 2A, e). Likewise in slices treated
with O1 antibody and complement, the number of O1+ cells was
virtually zero after 24 h (Fig. 2A, f) while the number of A2B5+ cells
(Fig. 2A, c)was essentially unaffected compared to controls (Fig. 2A, a, d).
At this stage neither treated nor control slices contained signiﬁcant
numbers of MBP+ cells. Quantitative data are shown in Fig. 2B and C.
In parallel studies, the efﬁcacy of selective cell ablation was
assessed in dissociated cell cultures. In control cultures, A2B5-
immunopositive cells account for 85%, O4-immunopositive cells for
8% and O1-immunopositive cells for 6% of the total cell number. After
complement-mediated lysis of the A2B5+ cells, as expected the
number of A2B5+ cells was reduced nearly to zero. The total number
of O1-immunopositive cells, however, was not statistically different in
A2B5-depleted cultures (Fig. 3B) when compared with non-treated
cell culture (Fig. 3A). Quantiﬁcation of these results (Fig. 3C) conﬁrms,
ﬁrst, that O1+ immature oligodendrocytes have been generated at
the time of complement lysis of the mixed cell cultures and, second,
that the A2B5 progenitors can be selectively depleted with little to no
change in the number of O1 oligodendrocytes retained in the culture.
Together, these data demonstrate the capability of eliminating
distinct populations of cells of the oligodendrocyte lineage through
complement-mediated cell lysis. Ablation of A2B5+ cells eliminates a
subset but not all NG2+ cells while ablation of O1+ immature
oligodendrocytes does not affect the population of OPCs.
In control slice cultures, there is a signiﬁcant overlap in the
expression of A2B5 (red) and NG2 (Green) on OPCs (Fig. 4a–c);
however, a discrete population of NG2+/A2B5− cells is also present
and are retained following ablation of A2B5+ cells (Fig. 4d–f). Parallel
studies with O1 targeted complement lysis do not substantially alter
the composition of the pool of OPCs (Fig. 4g–i). These data suggestFig. 3. The number of O1+ immature oligodendrocytes remains unchanged before and after
cells were found in untreated primary brain mixed culture after 24 h. In cultures exposed to
and quantiﬁcation (C) shows that the number of O1-positive cells is not signiﬁcantly differthat there is a residual population of potential OPCs after A2B5-
mediated complement cell lysis that could replace eliminated cells.
To determine whether complement-mediated cell lysis stimulated
amicroglial response, slice cultures were labeledwith IBA1 antibodies
in control slices and in slices after A2B5 or triple antibody-mediated
cell lysis (Fig. 4j–l). No increase in IBA1 labeling was seen in slices in
which cell lysis was induced, suggesting either that in this setting,
the microglia are not stimulated by complement-mediated cell
lysis or that the microglia are already highly stimulated by the slice
preparation.
Oligodendrocyte maturation and myelin formation are delayed after
ablation of both OPCs and immature oligodendrocytes
To determine the effects of ablation of both OPCs and early
oligodendrocytes on the development of MBP+ cells and myelination,
slices were treated with a combination of A2B5, O4, and O1 antibodies
and complement and the number of MBP+ cells compared to controls.
After 2 rounds of treatments, treated slices were cultured in vitro for
3 days (P2+3 DIV). While normal numbers of MBP+ cells developed
in slice cultures exposed to antibodies or complement alone, very few
MBP+ cells were present in experimental slice cultures suggesting that
removal of OPCs and early oligodendrocytes delayed the development
of MBP+ cells (Fig. 5A, d) (the residual MBP labeling was associated
with cell debris). This delay was transient. At P2+7 DIV increasing
numbers ofMBP+cells developed (Fig. 5A, e) although these cellswere
relatively immature in their morphologywith short radial processes. By
P2+14 DIV (Fig. 5A, f) signiﬁcantly more MBP+ cells were present in
both treated and untreated slices andmanyof these cells possessed long
processes. Compared to control slices (Fig. 5A, a–c), however, the
number of MBP+ oligodendrocytes was signiﬁcantly reduced and the
orientation of the oligodendrocyte processes far more random. This
likely reﬂects alterations in the cytoarchitecture of the slice following
cell ablation. Quantiﬁcation of MBP expression conﬁrmed the develop-
mental delay. In both control and experimental slices, the level of MBP
expression increased over the 14-day culture interval (Fig. 5B) although
the levels in slices treated with antibodies and complement never
achieved the same level of expression as seen in controls. These studies
demonstrate the potential for recovery ofmyelinating oligodendrocytes
following the elimination of the majority of oligodendrocyte lineagecomplement-mediated A2B5+ cell ablation in dissociated cell cultures. A, O1-positive
A2B5 plus complement-mediated lysis (A2B5+C), O1-positive cells are still present (B)
ence in treated and untreated cell cultures (pN0.05). Scale bar=25 μm.
Fig. 4. Ablation of A2B5+ cells reduces the density of NG2+ cells while ablation of O1+ cells does not dramatically affect NG2+ cell numbers. Complement-mediated cell lysis in
slice cultures does not stimulate a widespread microglial response. Control cultures show signiﬁcant overlap in expression of A2B5 (red) and NG2 (green) on OPCs (a–c). A discrete
population of NG2+ cells is also present and is retained following ablation of A2B5+ cells (d–f). Parallel studies with O1 targeted complement lysis do not substantially alter the
composition of the pool of OPCs (g–i). To determine whether complement-mediated cell lysis stimulated a microglial response, slice cultures were labeled with IBA1 antibodies in
controls and after A2B5 or triple antibody-mediated cell lysis (j–l). No increase in IBA1 staining obviously accompanied cell lysis. Scale bar=25 μm.
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restricted to slice preparations, similar studies were conducted on
dissociated cell cultures. Ablation of A2B5+, O4+, and O1+ cells
resulted in signiﬁcantly reduced numbers of MBP+ cells after 3 days
(Fig. 5A, j, and C). The number of MBP+ cells increased over time and
developed increasingly complex morphologies (Fig. 5A, k, and l) such
that by P2+14 DIV they extended numerous MBP+ processes.
Although the proportion of MBP+ cells increased in experimental
cultures, they failed to recover to control levels within 14 DIV. Together
these data suggest that the residual oligodendrocytes lineage cells in
complement treated cultures are capable of generating MBP+ cells in
reducednumbers and after a temporal delay. The delayed appearance of
MBP+ cells likely reﬂects the recruitment and maturation of residual
and pre-A2B5+ cells in experimental cultures.
Myelination is delayed after ablation of early stage progenitors
Since ablation of OPCs and early oligodendrocytes reduces the
number and delays development of MBP+ cells, we hypothesized thatselective ablation of early OPCs would reduce the initial number of
OPC lineage cells but not alter the timing of MBP+ cell appearance. To
test this hypothesis, slice cultures were treated with A2B5+ and
complement to eliminate OPCs but retain O1+ immature oligoden-
drocytes and the appearance of MBP+ cells was assayed. In contrast
to the anticipated results, the appearance of MBP+ cells was
signiﬁcantly delayed after treatment with A2B5 and complement
(Fig. 6). For example, treated slices contained only occasional MBP+
cells, presumably derived from A2B5+ progenitors until P2+14 DIV
(Fig. 6A, d–f) while control slices contained substantial numbers of
MBP+ cells by P2+3 DIV (Fig. 6A, a). Since A2B5 plus complement-
mediated lysis did not alter O1+ immature oligodendrocyte numbers
after 24 h (Fig. 3), these data suggest that in the absence of A2B5+
OPCs, the maturation of oligodendrocytes is delayed. A similar delay
in the appearance of MBP+ cells was seen using a combination of
A2B5 and O4 to target cell ablation (Fig. 6A, g–i). The delay in MBP+
cell appearance was supported by quantiﬁcation of MBP expression
where the average intensity (pixel) of labeling was signiﬁcantly lower
in experimental cultures than in untreated controls at P2+3 DIV and
Fig. 5.Myelin formation is delayed in the absence of all stages of the committed OPC lineage. Cultured slices were treated with A2B5, O4, and O1 antibodies simultaneously, followed
by complement-mediated lysis. While some occasional MBP+ process were detectable, few MBP+ cells (red) were seen P2+3 DIV (A, d) and appeared unhealthy compared to
untreated P2+3 DIV slices (A, a). In the treated groups, MBP+ cells with few myelinated ﬁbrils appear by P2+7 DIV (A, e) and increase by P2+14 DIV(A, f), but myelination was
signiﬁcantly reduced compared to the non-treated slices at the same ages (A, b–c). Similar results were found in primary dissociated brain mixed cell cultures (A, g–l). Quantitation
of MBP ﬂuorescence intensity (pixel) shows signiﬁcantly decreased MBP intensity in triple-treated slice cultures (pb0.01) compared to untreated slice cultures (B). Quantitation of
the percent of MBP+ cells in treated dissociated cell cultures demonstrated a signiﬁcant decrease (pb0.01) compared to untreated cultures (C). Scale bar =25 μm.
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until P2+14 DIV, the longest time point examined. Together these
data imply that OPCs inﬂuence the timing of onset of myelination by
oligodendrocytes.
Ablation of A2B5+ OPCs also inhibited oligodendrocyte matura-
tion in dissociated cell culture. While control cultures contained
signiﬁcant numbers of MBP+ cells at P2+3 DIV (Fig. 6A, j) and these
increased by P2+7 DIV (Fig. 6A, k), cultures treated with A2B5
antibody and complement contained only an occasional MBP+ cell at
P2+3 DIV (Fig. 6A, m, p) and very few at P2+7 DIV (Fig. 6A, n, q). By
P2+14 DIV, the number of MBP+ cells in A2B5+C or A2B5+O4+C
treated cultures had increased (Fig. 6A, o, r) but failed to achieve levelsseen in controls (Fig. 6A, l). Furthermore in A2B5+C treated cultures,
the expression of MBP on individual cells was relatively low and
restricted to the cell body with a relatively immature morphology
(Fig. 6A, o, r).Failure of MBP+ cells to develop after ablation of immature
oligodendrocytes
Ablation of O1+ immature oligodendrocytes, the direct precursor
of MBP+ cells, would be predicted to delay the appearance of MBP+
cells in slice cultures. To test this hypothesis, O1+ cells were ablated
134 Y. Yang et al. / Developmental Biology 350 (2011) 127–138
135Y. Yang et al. / Developmental Biology 350 (2011) 127–138by complement-mediated cell lysis at P2 slice cultures and the
development of MBP expression assessed.
Selective ablation of O1+ cells inhibited the appearance of MBP+
cells. In contrast to the delay seen after ablation of OPCs and early
oligodendrocytes, in O1+ complement treated slices, the develop-
ment of MBP+ cells was dramatically inhibited up to 14 days in
culture, the longest time examined. In contrast to controls, while an
occasional MBP+ cell was present at P2+3 and P2+7, the numbers
failed to increase (Fig. 7A, d, e). Not only were MBP+ cell bodies
absent but also no myelinated axons were detectable in O1+
complement treated slice cultures even when these were maintained
for P2+14 (Fig. 7A, f). In contrast, control cultures developed a
signiﬁcant number of myelinated axons (Fig. 7A, a–c). The failure of
MBP+ cells to develop after O1 and complement-mediated cell lysis
was not restricted to slice cultures. Ablation of O1+ immature
oligodendrocytes in mixed dissociated cell culture resulted in a
permanent loss of MBP+ cells, at least up to P2+14 DIV. In control
cultures, the total number of process bearing MBP+ cells increased
throughout the culture period (Fig. 7A, g–i). By contrast, only
occasional morphologically immature MBP+ cells were detected in
treated cultures at all stages examined (Fig. 7A, j–l). Statistical
quantiﬁcation of signiﬁcant difference of the number of MBP+ cells
(Fig. 7B) and the ﬂorescence intensity (pixel) of MBP expression
(Fig. 7C) conﬁrmed the permanent reduction seen in cultures
following elimination of O1+ cells. These data suggest that in the
absence of an appropriate cohort of O1+ immature oligodendrocytes,
residual progenitors are unable to mature to MBP+ cells.
Growth factor stimulation partially overcomes the O1+ cells ablation
induced block of oligodendrocyte maturation
Previous studies have demonstrated that platelet-derived growth
factor (PDGF) canmodulate proliferation and survival ofOPCs (Hart et al.,
1989; Noble et al., 1988; Woodruff et al., 2004). Addition of exogenous
PDGF (10 ng/ml) to O1+ cell depleted slice cultures resulted in a
partial recovery of the number of MBP+ cells after P2+7 and P2+14
(Fig. 8c–d) compared to cultures without PDGF (Fig. 8a–b) suggesting
that the inhibition of oligodendrocyte maturation induced by ablation of
O1+ cells can be partially overcome by extrinsic signals.
Discussion
The development of oligodendrocytes and myelin formation is
critical for the normal functioning of the vertebrate central nervous
system. Studies in dissociated cell culture have provided considerable
insights into OPC biology (Barres and Raff, 1994; Miller, 2002);
however, less is known about the onset of myelination by oligoden-
drocytes in part due to the lack of robust easily manipulated models.
Here we utilize a developing forebrain slice culture that allows for the
analysis of all stages of the oligodendrocyte lineage including the
onset of myelination.We show that in control slices, the timing of OPC
development, oligodendrocyte differentiation and maturation, as well
as the onset of myelination closely reﬂects that seen in vivo,
consistent with previous studies (Notterpek et al., 1993).
Through the selective ablation of distinct populations of cells, we
reveal an unexpected regulatory mechanism of oligodendrocyte
maturation dependent upon interactions between stages of the
oligodendrocyte lineage that modulates the timing of cell maturationFig. 6.Myelination is delayed after depleting early stage OPC progenitors. After depleting ear
are seen at P2+3DIV (A, d, g) and at P2+7DIV(A, e, h). In untreated cultures, MBP+ cells w
started by P2+7 DIV (A, b). By P2+14 DIV, MBP+ processes appeared in the treated culture
contain robust, parallel myelinated ﬁbrils at P2+14 DIV (A, c). Similar results were found in p
or A2B5+ and O4+ cells together (A, p–r). Untreated cell cultures are shown in A, j–l. Quanti
cells in cultures are shown in B, a–d. After depletion of A2B5+ cells alone or A2B5+ plu
decreased (**pb0.01) compared to untreated slice cultures (B, a, c). Even at P2+14 DIV, whe
cultures (*pb0.05). The percentage of MBP-positive cells is signiﬁcant decreased (**pb0.01and onset ofmyelination. Targeting complement-mediated cell ablation
with mAb A2B5 eliminates essentially all A2B5+ cells but has no
immediate appreciable effect on the number of O1+ cells. Likewise,
targeting complement-mediated cell lysis with mAb O1 eliminates
essentially all O1+ cells but has no immediate appreciable effect on the
number of A2B5+ cells demonstrating the capability to selectively
eliminate cells at distinct stages of oligodendrocyte maturation. Using a
combination of A2B5, O4 and O1 antibodies together to target
complement-mediated cell lysis, the majority of cells of the oligoden-
drocyte lineage were selectively eliminated in slice cultures. This cell
loss resulted in a signiﬁcant delay in the appearance ofmature (MBP+)
oligodendrocytes as well as a reduction in their overall numbers.
Selective ablation of A2B5+ oligodendrocyte precursors unexpectedly
resulted in a similar delay in the appearance ofMBP+cells. This delay in
oligodendrocytematurationwas not restricted to slice cultures. Parallel
studies with dissociated cell cultures resulted in similarly delayed MBP
appearance. In contrast, selective ablation of O1+ immature oligoden-
drocytes in either slice or dissociated cell cultures resulted in a blockade
of MBP cell appearance even though the numbers of A2B5+ progenitor
cells were unaffected. These data suggest that maturation of cells of the
oligodendrocyte lineage is regulated in part through feed-forward and
feedback mechanisms between the stages of the oligodendrocyte
lineage. Such regulatory mechanisms may have important implications
for both the development of myelination and remyelination.
Two mechanisms could account for the capacity of slice cultures to
recover MBP+ cells after ablation of multiple stages of the oligoden-
drocyte lineage. Itmay be that a residual pool of A2B5+OPCs remains in
the slice following complement-mediated lysis and these cells subse-
quently proliferate and repopulate the entire lineage. Alternatively, a
pre-OPC population (Armstrong, 2007; Baracskay et al., 2007; Nait-
Oumesmar et al., 1999) could regenerate the entire lineage. Several
sources of pre-OPCs have been described (Nait-Oumesmar et al., 1999;
Wu et al., 2009). For example, the slices contain regions of the
ventricular zones that are known to harbor neural stem cells (Wu
et al., 2009) while in the developing cortex NG2+ cells represent OPCs
and may be the ancestors to A2B5+ cells (Baracskay et al., 2007;
Nishiyama et al., 2009; Yoo andWrathall, 2007; Zhu et al., 2008). These
cells are retained after ablation of A2B5+ cells may subsequently
repopulate the lineage. Regardless of the speciﬁc cellular source, the
ability of the oligodendrocyte lineage to generate MBP+ cells after
removal of themajority of OPCs and oligodendrocytes demonstrates the
remarkable regenerative capacity of this lineage. At the time of cell
ablation, no MBP+ cells had developed in the slice cultures so their
appearance 3 days after treatment and the increase in cell numbers that
approximately parallels that of controls over the subsequent 11 days
suggests MBP+ cells can develop from pre-OPCs within 3 days.
While the delay in MBP+ cell appearance after ablation of the
majority of cells of oligodendrocyte lineage is easily understood, it is
less obvious why elimination of A2B5+ OPCs results in delayed
appearance of MBP+ cells. Given that the number of O1+ cells was
not immediately affected by A2B5 targeted complement-mediated
cell lysis, it might have been anticipated that the residual, more
mature oligodendrocyte lineage cells would have differentiated
according to their intrinsic schedule (Temple and Raff, 1986) resulting
in no changes in the timing of initial appearance but a reduction in
subsequent number of MBP+cells. By contrast, the delay in MBP+cell
expression strongly suggests that the timing of oligodendrocyte
maturation is inﬂuenced by the number or density of OPCs (Nakatsujily progenitors (A2B5+ cells or A2B5+ and O4+ cells), only a few immature MBP+ cells
eremorphologically healthy andmoremature at P2+3 DIV (A, a), and process extension
(A, f, i) but were delayed and disorganized compared to the untreated slice cultures that
rimary brain dissociatedmixed cell cultures after ablation of A2B5+ cell alone (A, m–o)
tative analysis of MBP ﬂuorescence intensity (pixel) and the percentage of MBP-positive
s O4+ progenitors in slice cultures, the intensity of MBP ﬂuorescence is signiﬁcantly
nMBP intensity continues to increase, it is still signiﬁcantly lower than in untreated slice
) in brain dissociated mix cell cultures (B, b, d). Scale bar=25 μm.
Fig. 7. Lack of myelin formation and oligodendrocyte maturation in the absence of O1+ immature oligodendrocytes. In slice cultures (a–f) and dissociated cell cultures (g–i) the
maturation of oligodendrocytes is dependent on the presence of O1+ cells. FewMBP+ cell bodies were found at P2+3 DIV (A, d) and P2+7DIV (A, e) following elimination of O1+
cells. MBP+ processes failed to develop in treated cultures even at P2+14 DIV (A, f). Untreated slice cultures are shown in A, a–c. In mixed cell cultures (g–i) treated with O1 plus
complement (O1+C), MBP+ cells were reduced and showed no extended MBP+ processes even at P2+14 DIV (A, j–l). In untreated cell cultures, advanced MBP+ cells were seen
in increased numbers and had complex and extended processes (A, g–i). Quantitative analysis is shown in B for dissociated cell cultures and in C for brain slice cultures. *pb0.05
versus control; **pb0.01 versus control. Scale bar=25 μm.
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Fig. 8. PDGF promotes myelination even in the absence of O1+ immature oligodendrocytes in slice cultures. After addition of 0.1% PDGF to slice cultures lacking O1+ progenitors,
MBP+myelinated ﬁbrils appear by P2+7 in slice culture (c) and robust MBP+myelination was seen in P2+14 slices (d). In contrast, nomyelinated axons were observed in P2+14
slices after ablation of O1+ immature oligodendrocytes without the addition of PDGF (a–b). Scale bar=25 μm.
137Y. Yang et al. / Developmental Biology 350 (2011) 127–138and Miller, 2001; Zhang and Miller, 1996). These ﬁndings implicating
a community effect are consistent with a model in which a critical
number of OPCs are generated prior to the initiation of myelination
(Calver et al., 1998; Zhang and Miller, 1996) and would explain how
speciﬁc regions of the CNS can myelinate extremely rapidly during
development. In addition, morphological studies have suggested that
some chronic demyelinated plaques in patients with multiples
sclerosis contain signiﬁcant numbers of premyelinating oligodendro-
cytes in close association with viable axons (Chang et al., 2000;
Zawadzka and Franklin, 2007). It may be that the paucity of OPCs in
these regions contributes to the blockade of the further maturation
and myelination of these cells. Other mechanisms such as the
presence of elevated levels of inhibitors of OPC differentiation such
as LINGO-1 or the lack of appropriate stimuli are also likely to
contribute to the blockade of remyelination (Mi et al., 2005; Mi et al.,
2009; Mi et al., 2008; Miller and Mi, 2007).
The inability of the oligodendrocyte lineage to recover from ablation
of O1+ cells although the number of A2B5+ cells is unaffected is
unexpected. Since in the setting of slice culturesMBP+cells can develop
from pre-OPCs within 3 days, their appearance on a similar time frame
was anticipated. By contrast, even after 14 days MBP+cells failed to
emerge in signiﬁcant numbers after O1 targeted ablation. Theseﬁndings
may reﬂect a mechanism by which developing OPCs have a speciﬁc
window in which to initiate myelination and mAb O1 complement-
mediated ablation disrupts that window (Dugas et al., 2007; Emery
et al., 2009). More likely, the residual A2B5+ cells in the slice are
dependent on the presence of O1+ cells for their continuedmaturation.
Onepossiblemechanism for suchaneffect is thatO1+cells facilitate the
production of OPC mitogens such as PDGF from astrocytes and other
cells in the surrounding tissue possibly by enhancing axonal electrical
activity (Fields, 2005; Fields and Stevens-Graham, 2002; Ishibashi et al.,
2006) and that this mitogenic activity drives OPC differentiation and
maturation. Several lines of evidence are consistent with this hypoth-
esis. First, there is a close relationship between OPC proliferation and
differentiation (Raff et al., 1984b) thatmay bemediated by cell intrinsic
regulatory mechanisms (Cayouette et al., 2003; Dugas et al., 2007; Gao
et al., 2006; Miller, 2002; Temple and Raff, 1986). Second, in spinal cord
cultures oligodendrocytes tend to differentiate in spatially deﬁned
clusters that are not always clonally related (Zhang and Miller, 1996)suggesting that the presence of differentiated OPCs enhances the
differentiation potential of adjacent cells. Third, addition of exogenous
PDGF to O1+ cell depleted slices resulted in a partial recovery ofMBP+
cells. Alternatively, the presence of sufﬁcient numbers of O1+cellsmay
provide protection for the survival of premyelinating OPCs that is
known to be dependent on PDGF (Murtie et al., 2005).
Together, these data argue that the different stages of OPC
development and oligodendrocyte maturation are intimately interre-
lated and interact with each other during the development process.
There is an unexpected feedback relationship from the later to the
earlier stage cells that has a strong inﬂuence on the ability of the
earlier stages to complete their differentiation into myelin-forming
oligodendrocytes. Local environmental cues as well as balance among
the different stages of the oligodendrocyte lineage are critical in
regulating the differentiation of oligodendrocytes to mature myelin-
forming cells. Identifying the molecular mediators of this complex
phenomenon will have important implications for understanding
critical aspects of neural development and generating novel effective
repair strategies for demyelinating diseases.Acknowledgments
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